Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04314128
Other study ID # H-19029542
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 1, 2020
Est. completion date February 1, 2023

Study information

Verified date March 2023
Source Danish Headache Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Idiopathic Intracranial Hypertension (IIH) is a rare disease, primarily affecting overweight females of child-bearing age. Patients suffer from increased intracranial pressure (ICP), typically resulting in headaches, visual disturbances and bilateral papilledema, pulsatile tinnitus and cognitive deficits. The disease is difficult to diagnose, treat and monitor. The only current method of measuring the ICP in day-to-day clinical practice is by lumbar puncture. This procedure is invasive, and often painful for the patient. There is an unmet need of methods that can reliable measure or estimate ICP in a non-invasive manner. Ultrasound is one such potential method, and the aim of this study is to investigate the use of ocular ultrasound and transcranial doppler to measure or estimate ICP.


Description:

This study is a prospective cohort study. Investigators plan to include 50 patients in whom the IIH-diagnosis is suspected. Patients are referred from general practitioners, neurologists or ophthalmologists to the Danish Headache Center or admitted to the Neurology ward when the IIH diagnosis is suspected. As part of an established routine clinical work-up to establish the diagnosis of IIH, all patients will undergo (according to the Friedman criteria) the following examinations: A) 1. An interview (history taking) and clinical examination 2. Routine laboratory tests (blood tests) 3. Ophthalmological examination 4. Lumbar puncture with measurement of the ICP 5. Magnetic resonance imaging (MRI) of the brain Additionally the following investigations will be performed at baseline (before and after lumbar puncture): B) Transorbital sonography (TOS) C) Transcranial Doppler When the patient is seen at the clinic for their regular follow-up visits the same measurements will be done. A control group of healthy participants (NR=25) will be included in whom TOS (B) and TCD (C) will be performed in order to compare the values between the patient group (IIH) and control group. Controls will be included to match the patients according to BMI, age and gender. All ultrasound images- and films will be saved, and evaluated by a blinded investigator.


Recruitment information / eligibility

Status Completed
Enrollment 78
Est. completion date February 1, 2023
Est. primary completion date February 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility PATIENT GROUP (ARM 1): Inclusion Criteria: - Age 18-65 - Patients in whom the IIH diagnosis is suspected/or confirmed - The diagnosis of migraine with or without aura or tension-type headache is allowed as a comorbid headache type. - Participants must read and understand the Danish language, or have an official interpreter present to be able to understand the work-up and sign the participation consent for the study Exclusion Criteria: - Pregnant or breastfeeding females - Patients who do not need a diagnostic lumbar puncture at the time of evaluation - Patients treated with acetazolamide, topiramate or furosemide for IIH or suspected IIH before inclusion in the study (baseline) - Any other primary or secondary headache diagnosis than migraine with or without aura or tension type headache as a comorbid disorder - Patients in whom the examination cannot be performed due to anatomical reasons such as severe head dysmorphia or severe ophthalmological diseases - Participants with secondary causes of raised intracranial pressure, or patients that have been treated for such (e.g. brain tumor, hydrocephalus, stroke or severe head injury) - Participants with known atherosclerotic disease or known heart disease CONTROL GROUP (ARM 2): Inclusion criteria: - Age 18-65 - Healthy persons who do not suffer from any form of primary headache except infrequent tension-type headache - Participants must read and understand the Danish language or have an official interpreter present to be able to sign the participation consent for the study. Exclusion criteria: - Pregnant or breastfeeding females - Participants in whom the examination cannot be performed due to anatomical reasons such as severe head dysmorphia or severe ophthalmological diseases

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
TOS and TCD
TOS: Transorbital sonography TCD: Transcranial Doppler

Locations

Country Name City State
Denmark Danish Headache Center Glostrup Region Hovedstaden

Sponsors (1)

Lead Sponsor Collaborator
Danish Headache Center

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Primary Correlation between opening pressure and ONSD Optic nerve sheath diameter (ONSD) potential correlation with opening pressure. 1 year
Primary Correlaton between opening pressure and ONSD/ETD ratio ONSD/ETD (external transverse diameter) ratio and potential correlation with opening pressure. 1 year
Primary Comparison of ONSD in IIH and healthy controls Comparison of ONSD in patients with elevated ICP (IIH) and healthy controls, age- sex and BMI matched. 1 year
Secondary Optic disc elevation Optic disc elevation measured by ultrasound in IIH compared with healthy controls 1 year
Secondary ONSD diameter on MR c in patients with IIH ONSD and correlation with ONSD on orbital MRI. 1 year
Secondary Changes in the optic nerve (ONSD) Changes in ONSD after 1 month 1 month
Secondary Changes in the optic nerve (ONSD) Changes in ONSD after 6 months 6 months
Secondary Changes in the optic nerve (ODE) Changes in ODE (optic disc elevation) after 1 month 1 month
Secondary Changes in the optic nerve (ODE) Changes in ODE(optic disc elevation) after 6 months 6 months
Secondary TCD (PI - pulsatility index) in patients with IIH Evaluation of pulsatility index for major intracranial arteries (PI) using doppler ultrasound in patients with raised intracranial pressure (IIH) compared with normal values. 2 years
Secondary TCD (MBFV - mean blood flow velocity) in patients with IIH Evaluation of mean blood flow velocity (MBFV) for major intracranial arteries using doppler ultrasound in patients with raised intracranial pressure (IIH) compared with normal values. 2 years
Secondary TCD (RI - resistance index) in patients with IIH Evaluation of resistance index (RI) for major intracranial arteries using doppler ultrasound in patients with raised intracranial pressure (IIH) compared with normal values. 2 years
Secondary Neuro-ophthalmological evaluation of papilledema versus ultrasound evaluation of the optic nerve Papilledema and the optic nerve is usually evaluated by neuro-ophthalmologists in patients with IIH. Investigators will compare this evaluation with the assessment made by TOS ultrasound. 2 years
See also
  Status Clinical Trial Phase
Terminated NCT01863381 - Comparison of Continuous Non-Invasive and Invasive Intracranial Pressure Measurement N/A
Recruiting NCT06027567 - The Effect of an Anti-obesity Drug, Semaglutide, as Treatment in New-onset Idiopathic Intracranial Hypertension (IIH) Compared to Standard Weight Management (Dietician) With Regards to Change in Weight and Intracranial Pressure Phase 4
Active, not recruiting NCT02896452 - Astronaut Vision Issues in a Ground Analog Population: Polycystic Ovary Syndrome
Recruiting NCT06059703 - Biomarkers in the Etiology of Idiopathic Intracranial Hypertension N/A
Terminated NCT05347147 - A Trial to Determine the Efficacy and Safety of Presendin in IIH Phase 3
Not yet recruiting NCT06361823 - Exploratory Study on the Efficacy and Safety of Semaglutide for Idiopathic Intracranial Hypertension Treatment Phase 3
Active, not recruiting NCT02124486 - An RCT of Bariatric Surgery vs a Community Weight Loss Programme for the Sustained Treatment of IIH N/A
Recruiting NCT02143258 - Stenting of Venous Sinus Stenosis for Medically Refractory Idiopathic Intracranial Hypertension N/A
Enrolling by invitation NCT05308823 - Outcome of Cerebral Venous Sinuses Stenting on Idiopathic Intracranial Hypertension N/A
Not yet recruiting NCT05762367 - MR Lymphatic Imaging in Idiopathic Intracranial Hypertention N/A
Not yet recruiting NCT06436820 - ICP & Outflow Study
Completed NCT03867461 - The Effects of MAP and EtCO2 on Venous Sinus Pressures N/A
Completed NCT03963336 - Quantitative D-dimer Level and Anticoagulant Therapy in Idiopathic Intracranial Hypertension Early Phase 1
Completed NCT01003639 - Idiopathic Intracranial Hypertension Treatment Trial Phase 2/Phase 3
Recruiting NCT03096743 - Evaluating Raised Intracranial Pressure Using MR Elastography N/A
Terminated NCT03501966 - Surgical Idiopathic Intracranial Hypertension Treatment Trial Phase 3
Active, not recruiting NCT03556085 - Venous Sinus Stenting With the River Stent in IIH N/A
Completed NCT02017444 - Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension. Phase 2